美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Alamar Biosciences, Inc.

17.00

0.0000

成交量：- -

成交額：- -

市值：11.03億

市盈率：-6.87

高：- -

開：- -

低：- -

收：17.00

52周最高：- -

52周最低：- -

股本：6,489.08萬

流通股本：937.50萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.4751

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Alamar Biosciences, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.alamarbio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Alamar Biosciences, Inc.於2018年5月7日在特拉華州註冊成立，總部位於加利福尼亞州弗里蒙特市。該公司是一家商業化階段的蛋白質組學公司，致力於建立蛋白質檢測和分析的黃金標準。公司提供專有的NULISA平台，該平台能夠以超高靈敏度、高特異性、靈活的多重檢測、寬動態範圍和自動化，檢測非侵入性生物體液中的低丰度蛋白質生物標誌物，從而實現“精準蛋白質組學”。公司提供儀器、耗材和分析軟件的集成解決方案，用於發現、轉化研究和診斷開發。

董事

名稱

職位

Yuling Luo

Chief Executive Officer and Chairman

Shiping Chen

Chief Operating Officer and Director

Frank R. Witney

Director

Ian W. Ratcliffe

Director

Nicholas Naclerio

Director

Rebecca Chambers

Director

股東

名稱

職位

Yuling Luo

Chief Executive Officer and Chairman

Shiping Chen

Chief Operating Officer and Director

Justin McAnear

Chief Financial Officer

Timothy White

President

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ALMR/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences, Inc.","latestPrice":17,"timestamp":1776369600000,"preClose":17,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":9375000,"shares":64890799,"eps":-2.475102,"marketStatus":"待開盤","change":0,"latestTime":"04-16 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.475102,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776432600000},"marketStatusCode":16,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","floatShares":9375000,"roa":"--","roe":"--","lyrEps":0,"shares":64890799,"dividePrice":0,"high":0,"amplitude":0,"preClose":17,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":17,"eps":-2.475102,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.475102,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMR\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.alamarbio.com","compareEarnings":[{"period":"1week","weight":0.032},{"period":"1month","weight":0.046},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.0561},{"period":"1year","weight":0.3348},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Alamar Biosciences, Inc.於2018年5月7日在特拉華州註冊成立，總部位於加利福尼亞州弗里蒙特市。該公司是一家商業化階段的蛋白質組學公司，致力於建立蛋白質檢測和分析的黃金標準。公司提供專有的NULISA平台，該平台能夠以超高靈敏度、高特異性、靈活的多重檢測、寬動態範圍和自動化，檢測非侵入性生物體液中的低丰度蛋白質生物標誌物，從而實現“精準蛋白質組學”。公司提供儀器、耗材和分析軟件的集成解決方案，用於發現、轉化研究和診斷開發。","exchange":"NASDAQ","name":"Alamar Biosciences, Inc.","nameEN":"Alamar Biosciences"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ALMR\",market:\"US\",,,undefined,":{"directors":[{"name":"Yuling Luo","position":"Chief Executive Officer and Chairman"},{"name":"Shiping Chen","position":"Chief Operating Officer and Director"},{"name":"Frank R. Witney","position":"Director"},{"name":"Ian W. Ratcliffe","position":"Director"},{"name":"Nicholas Naclerio","position":"Director"},{"name":"Rebecca Chambers","position":"Director"}],"executives":[{"name":"Yuling Luo","position":"Chief Executive Officer and Chairman"},{"name":"Shiping Chen","position":"Chief Operating Officer and Director"},{"name":"Justin McAnear","position":"Chief Financial Officer"},{"name":"Timothy White","position":"President"}]}}}